Sampedro B, Cabezas J, Fábrega E, Casafont F, Pons-Romero F
University Hospital Marqués de Valdecilla, Faculty of Medicine, Santander, Spain.
Transplant Proc. 2011 Apr;43(3):679-82. doi: 10.1016/j.transproceed.2011.01.084.
Orthotopic liver transplantation has shown successful results over the last years. For this reason there are increased numbers of patients on waiting lists. To expand the pool of liver donors, elderly donors have been used as a strategy.
We report our experience comparing donors of ≥ 75 years with younger ages for their characteristics, clinical outcomes, and survivals.
From January 2001 to December 2009, we performed 174 consecutive liver transplantation from cadaveric donors in 166 patients. During this period, we used 24 liver grafts from donors ≥ 75 years. We analyzed their outcomes retrospectively, describing donors and recipient characteristics and their clinical evolution.
The mean follow-up time among the entire study population was 42 ± 39 months. We observed an overall survival of 68.3% with similar incidences in both groups: 83% in the younger versus 78% in the older group at 1 year, and 69% versus 63%, at 5 years respectively. Both groups showed similar lengths of intensive care unit stay, cold and warm ischemia times, and intraoperative transfusion requirements. The older group had a total operative time than was longer and fewer hypotensive episodes than the younger group. There were no significant differences in the rates of rejection and retransplantation between the groups. The use of older donor livers was associated with a significantly higher rate of poor initial graft function (P = .027), an increased number of reinterventions (P = .013) in the older donor group, as well as more frequent vascular and biliar complications, without reaching significance.
Our data suggested that donor age alone did not engendered a survival disadvantage for graft or recipient. However, careful donor selection is needed to avoid additional risk factors that can increase the morbidity or mortality of the procedure.
在过去几年中,原位肝移植已取得成功结果。因此,等待名单上的患者数量有所增加。为了扩大肝脏供体库,已将老年供体作为一种策略。
我们报告比较75岁及以上供体与年轻供体的特征、临床结果和生存率的经验。
从2001年1月至2009年12月,我们对166例患者进行了174例连续尸体供肝肝移植。在此期间,我们使用了24例来自75岁及以上供体的肝脏移植物。我们对其结果进行了回顾性分析,描述了供体和受体的特征及其临床病程。
整个研究人群的平均随访时间为42±39个月。我们观察到总体生存率为68.3%,两组发生率相似:1年时年轻组为83%,老年组为78%;5年时分别为69%和63%。两组的重症监护病房住院时间、冷缺血和热缺血时间以及术中输血需求相似。老年组的总手术时间比年轻组长,低血压发作次数比年轻组少。两组之间的排斥反应和再次移植率无显著差异。使用老年供体肝脏与初始移植物功能不良的发生率显著更高(P = 0.027)、老年供体组再次干预次数增加(P = 0.013)以及更频繁的血管和胆道并发症相关,但未达到显著水平。
我们的数据表明,仅供体年龄并不会给移植物或受体带来生存劣势。然而,需要仔细选择供体以避免可能增加手术发病率或死亡率的其他危险因素。